A HEALTH and Pharmaceutical Investment Mission is set to be hosted from today (Monday, June 2, 2025), led by the European Union (EU) Delegation in collaboration with the Ministry of Health and the EU Chamber of Commerce in Guyana.

The three-day event, which runs until Wednesday, is being held at the Guyana Marriott Hotel and aims to connect local stakeholders with European health and pharmaceutical companies.
EU Ambassador to Guyana, Rene Van Nes, recently noted that, under the Global Gateway initiative, the EU will invest in local pharmaceutical development in both Guyana and Barbados.
He highlighted that a landmark joint declaration was signed last year to strengthen co-operation in pharmaceutical and regulatory services between Lithuania, Barbados, and Guyana.

To this end, Ambassador Van Nes explained that Lithuania had previously assisted Rwanda in establishing its pharmaceutical regulatory framework and that the same experts are now supporting Guyana in a similar effort.
“With that regulatory framework in place, Guyana will be open for business to start producing its own pharmaceuticals,” he said at the time.

The Ambassador further noted that a mission of European companies focused on health and pharmaceuticals with a keen interest in investing in Guyana is now underway. He also indicated that this model may be replicated in other sectors.

Over 13 companies from EU member states including Spain, Austria, France, the Czech Republic, Portugal, Sweden, Italy, and Ireland are expected to participate in the mission.
The mission is backed by the Guyana Office for Investment (Go-Invest), the Private Sector Commission, the Georgetown Chamber of Commerce and Industry (GCCI), the Guyana Manufacturers and Services Association (GMSA).

The mission will feature targeted seminars, business-to-business meetings, and site visits to medical and pharmaceutical facilities across the country.